Cargando…

Outcome of revision hip arthroplasty in patients younger than 55 years: an analysis of 1,037 revisions in the Dutch Arthroplasty Register

Background and purpose — The increasing use of hip arthroplasties in young patients will inevitably lead to more revision procedures at younger ages, especially as the outcome of their primary procedures is inferior compared with older patients. However, data on the outcome of revision hip arthropla...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuijpers, Martijn F L, Hannink, Gerjon, van Steenbergen, Liza N, Schreurs, B Willem
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144208/
https://www.ncbi.nlm.nih.gov/pubmed/31928096
http://dx.doi.org/10.1080/17453674.2019.1708655
_version_ 1783519793036394496
author Kuijpers, Martijn F L
Hannink, Gerjon
van Steenbergen, Liza N
Schreurs, B Willem
author_facet Kuijpers, Martijn F L
Hannink, Gerjon
van Steenbergen, Liza N
Schreurs, B Willem
author_sort Kuijpers, Martijn F L
collection PubMed
description Background and purpose — The increasing use of hip arthroplasties in young patients will inevitably lead to more revision procedures at younger ages, especially as the outcome of their primary procedures is inferior compared with older patients. However, data on the outcome of revision hip arthroplasty in young patients are limited. We determined the failure rates of revised hip prostheses performed in patients under 55 years using Dutch Arthroplasty Register (LROI) data. Patients and methods — All 1,037 revised hip arthroplasty procedures in patients under 55 years at the moment of revision registered in the LROI during the years 2007–2018 were included. Kaplan–Meier survival analyses were used to calculate failure rates of revised hip arthroplasties with endpoint re-revision for any reason. Competing risk analyses were used to determine the probability of re-revision for the endpoints infection, dislocation, acetabular and femoral loosening, while other reasons for revisions and death were considered as competing risks. Results — Mean follow-up of revision procedures was 3.9 years (0.1–12). 214 re-revisions were registered. The most common reason for the index revision was dislocation (20%); the most common reason for re-revision was infection (35%). The 5-year failure rate of revised hip prostheses was 22% (95% CI 19–25), and the 10-year failure rate was 28% (CI 24–33). The 10-year cumulative failure rates of index revisions with endpoint re-revision for infection was 7.8% (CI 6.1–9.7), acetabular loosening 7.0% (CI 4.1–11), dislocation 3.8% (CI 2.6–5.2), and femoral loosening 2.7% (CI 1.6–4.1). The 10-year implant failure rate of index revisions for infection was 45% (CI 37–55) with endpoint re-revision for any reason. Interpretation — Failure rate of revised hip prostheses in patients under 55 years is worrisome, especially regarding index revisions due to infection. This information facilitates realistic expectations for these young patients at the time of primary THA.
format Online
Article
Text
id pubmed-7144208
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-71442082020-04-13 Outcome of revision hip arthroplasty in patients younger than 55 years: an analysis of 1,037 revisions in the Dutch Arthroplasty Register Kuijpers, Martijn F L Hannink, Gerjon van Steenbergen, Liza N Schreurs, B Willem Acta Orthop Articles Background and purpose — The increasing use of hip arthroplasties in young patients will inevitably lead to more revision procedures at younger ages, especially as the outcome of their primary procedures is inferior compared with older patients. However, data on the outcome of revision hip arthroplasty in young patients are limited. We determined the failure rates of revised hip prostheses performed in patients under 55 years using Dutch Arthroplasty Register (LROI) data. Patients and methods — All 1,037 revised hip arthroplasty procedures in patients under 55 years at the moment of revision registered in the LROI during the years 2007–2018 were included. Kaplan–Meier survival analyses were used to calculate failure rates of revised hip arthroplasties with endpoint re-revision for any reason. Competing risk analyses were used to determine the probability of re-revision for the endpoints infection, dislocation, acetabular and femoral loosening, while other reasons for revisions and death were considered as competing risks. Results — Mean follow-up of revision procedures was 3.9 years (0.1–12). 214 re-revisions were registered. The most common reason for the index revision was dislocation (20%); the most common reason for re-revision was infection (35%). The 5-year failure rate of revised hip prostheses was 22% (95% CI 19–25), and the 10-year failure rate was 28% (CI 24–33). The 10-year cumulative failure rates of index revisions with endpoint re-revision for infection was 7.8% (CI 6.1–9.7), acetabular loosening 7.0% (CI 4.1–11), dislocation 3.8% (CI 2.6–5.2), and femoral loosening 2.7% (CI 1.6–4.1). The 10-year implant failure rate of index revisions for infection was 45% (CI 37–55) with endpoint re-revision for any reason. Interpretation — Failure rate of revised hip prostheses in patients under 55 years is worrisome, especially regarding index revisions due to infection. This information facilitates realistic expectations for these young patients at the time of primary THA. Taylor & Francis 2020-01-13 /pmc/articles/PMC7144208/ /pubmed/31928096 http://dx.doi.org/10.1080/17453674.2019.1708655 Text en © 2020 The Author(s). Published by Taylor & Francis on behalf of the Nordic Orthopedic Federation https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Articles
Kuijpers, Martijn F L
Hannink, Gerjon
van Steenbergen, Liza N
Schreurs, B Willem
Outcome of revision hip arthroplasty in patients younger than 55 years: an analysis of 1,037 revisions in the Dutch Arthroplasty Register
title Outcome of revision hip arthroplasty in patients younger than 55 years: an analysis of 1,037 revisions in the Dutch Arthroplasty Register
title_full Outcome of revision hip arthroplasty in patients younger than 55 years: an analysis of 1,037 revisions in the Dutch Arthroplasty Register
title_fullStr Outcome of revision hip arthroplasty in patients younger than 55 years: an analysis of 1,037 revisions in the Dutch Arthroplasty Register
title_full_unstemmed Outcome of revision hip arthroplasty in patients younger than 55 years: an analysis of 1,037 revisions in the Dutch Arthroplasty Register
title_short Outcome of revision hip arthroplasty in patients younger than 55 years: an analysis of 1,037 revisions in the Dutch Arthroplasty Register
title_sort outcome of revision hip arthroplasty in patients younger than 55 years: an analysis of 1,037 revisions in the dutch arthroplasty register
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7144208/
https://www.ncbi.nlm.nih.gov/pubmed/31928096
http://dx.doi.org/10.1080/17453674.2019.1708655
work_keys_str_mv AT kuijpersmartijnfl outcomeofrevisionhiparthroplastyinpatientsyoungerthan55yearsananalysisof1037revisionsinthedutcharthroplastyregister
AT hanninkgerjon outcomeofrevisionhiparthroplastyinpatientsyoungerthan55yearsananalysisof1037revisionsinthedutcharthroplastyregister
AT vansteenbergenlizan outcomeofrevisionhiparthroplastyinpatientsyoungerthan55yearsananalysisof1037revisionsinthedutcharthroplastyregister
AT schreursbwillem outcomeofrevisionhiparthroplastyinpatientsyoungerthan55yearsananalysisof1037revisionsinthedutcharthroplastyregister